PT-141 Explained: What It Does and Who Offers It

Quick answer: PT-141, also called bremelanotide, is a compound that acts on melanocortin receptors in the brain to affect sexual desire, rather than working on blood flow the way standard ED medications (sildenafil, tadalafil) do. It's FDA-approved on its own for low sexual desire in women (as Vyleesi), and used off-label as part of compounded formulas for men on this page.

How PT-141 Is Different From a Standard ED Pill

Sildenafil, tadalafil, vardenafil — the PDE5-inhibitor class that makes up most ED medication — work by relaxing blood vessels to increase blood flow. PT-141 doesn't touch that system at all. It acts on melanocortin receptors in the brain, a pathway linked to sexual desire and arousal rather than the physical mechanics of blood flow. That's why it's often positioned as an option for people whose ED has more to do with desire than with a blood-flow problem, or for people who haven't had success with standard PDE5 inhibitors.

Where It Actually Comes From

PT-141 (bremelanotide) has its own FDA-approved use — as Vyleesi, approved for premenopausal women with acquired hypoactive sexual desire disorder (HSDD). Its use in men's ED formulas is off-label and compounded, meaning it's prepared by licensed pharmacies combining it into men's-health formulas rather than sold as an FDA-approved product for that specific use.

Which Providers on This Page Offer It

Note: Rodeo uses apomorphine, not PT-141, for its desire-focused ingredient — a different compound with a related but distinct mechanism. Included above for context since it's frequently compared against PT-141-based options.

PT-141 Alone vs. PT-141 in a Blend

Telos Rx offers PT-141 on its own, with no PDE5 inhibitor included — the most direct way to try this specific mechanism. MadeMed combines it with tadalafil and oxytocin into one troche, pairing the desire-focused ingredient with a standard blood-flow medication in a single dose.